Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 121 |
|
|||||
| News | - | ||||||
| Day High | 27.44 | Low High |
|||||
| Day Low | 27.44 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Horizon Kinetics Medical ETF | MEDX | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0181 | -0.07% | 27.4879 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.44 | 27.44 | 27.44 | 27.4879 | 27.506 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8 | 121 | 27.44 | 3,320 | - | 27.0213 - 32.16 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 100 | 27.4879 | USD |
Horizon Kinetics Medical ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.04M | - | - | - | 21.37 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Horizon Kinetics Medical...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MEDX Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.34 | 27.90 | 27.32 | 27.59 | 276 | 0.1479 | 0.54% |
| 1 Month | 29.48 | 29.6344 | 27.32 | 28.47 | 1,062 | -1.99 | -6.76% |
| 3 Months | 28.45 | 30.62 | 27.32 | 29.19 | 820 | -0.9621 | -3.38% |
| 6 Months | 28.14 | 30.62 | 27.0213 | 28.66 | 1,102 | -0.6521 | -2.32% |
| 1 Year | 31.00 | 32.16 | 27.0213 | 29.52 | 1,079 | -3.51 | -11.33% |
| 3 Years | 31.10 | 32.65 | 27.0213 | 29.87 | 1,301 | -3.61 | -11.61% |
| 5 Years | 31.10 | 32.65 | 27.0213 | 29.87 | 1,301 | -3.61 | -11.61% |
| Horizon Kinetics Medical ETF seeks to provide long-term growth of capital. The Fund is an actively-managed exchange-traded fund (ETF) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks (such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and International Depositary Receipts (IDRs)) of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development, such as pharmaceutical development companies, surgical and medical instrument manufacturers and developers, pharmaceutical manufacturers, and biotech and medical research companies. |
